Prominex, Inc.
PrivateLast Round
Series B
Extension
Feb 24, 2020
Total Funding Raised
$19.2M
Company Overview
Prominex, Inc. operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Series B Extension round in February 2020.
Prominex, Inc. is a biotechnology company that develops rapid, point-of-care molecular diagnostic solutions for infectious disease testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prominex, Inc. Comparables
Compare Prominex, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VedaBio | 86% | |
| Anavasi Diagnostics | 85% | |
| Aptitude Medical | 80% |
For institutional investors. Book with your work email.
Prominex, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Feb 24, 2020 | ||||
| Series B | May 31, 2019 | ||||
| Series A Extension | Sep 13, 2018 | ||||
| Series A | Jan 5, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Prominex, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Casdin Capital | Series B, Series A, Series B Extension, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2025
Monthly visitors grew 269% MoM, from 325 to 1.2K.
- Feb 4, 2025
Grew 27% QoQ, from 11 to 14 employees.
For institutional investors. Book with your work email.
Prominex, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Prominex, Inc.'s valuation, stock price, and market status.
Is Prominex, Inc. a public or private company?
Prominex, Inc. is a private company.
What is the current stock price of Prominex, Inc.?
Prominex, Inc. is a private company, so its shares have no public market price. Caplight tracks Prominex, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Prominex, Inc. worth (valuation)?
Valuation information for Prominex, Inc. is not publicly available.
Can I buy Prominex, Inc. stock?
Prominex, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Prominex, Inc.'s last funding round?
Prominex, Inc.'s most recent funding round was Series B Extension on February 24, 2020.
Who are the main investors in Prominex, Inc.?
Key investors in Prominex, Inc. include Casdin Capital.
Will Prominex, Inc. IPO soon?
No public IPO plans have been announced for Prominex, Inc..
How can I track Prominex, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Prominex, Inc.'s shares on secondary markets.